维普中文期刊产品整合服务
93篇 您的检索式:作者名="PRESS OW"
    题名 作者 年代 出处 被引量
1Pivotal study of iodine I131 tositumomab for chemotherapy-refractory low-grade or transformedlow-grade B-cell non-Hodgkin's lymphomas显示文摘Kaminski MS Zelenetz AD Press OW 2001J Clin Oncol2001,19,19:1
2Signaling events involved in anti-CD20-induced apoptosis of malignant human B cells显示文摘Shan D Ledbetter JA Press OW 2000Cancer Immunol Immunother2000,48,12:1
3Cellular immunotherapy for follicular lymphoma using genetically modified CD20-Specific CD8 ^+ cytotoxic T lymphocytes 显示文摘Wang J Press OW Lindgren CG 2004Mol Ther2004,9,4:1
4Immunothetapy of nonhodgkin's lymphomas显示文摘Press OW Leonard JP Coiffier B 2001Hemotology2001,1,1:1
5New treatment options have changed the survival of patients with follicular lymphoma显示文摘Fisher RI LeBlanc M Press OW 2005J Clin Oncol2005,23,33:1
6Cellular immunotherapy for follicular lymphoma using genetically modified CD20-specific CD8^+ cytotoxic T lymphocytes显示文摘Wang J Press OW Lindgren CG 2004Mol Ther2004,9,4:1
7Principles of radioimmunotherapy for hematol- ogists and oncologists显示文摘Press OW Rasey J 2000Semin Oncol2000,27,612:1
8Cellular immunotherapy for follicular lymphoma using genetieally modified CD20-specifie CD^8+ cytotoxic T lymphoeytes 显示文摘Wang J Press OW Lindgren CG 2004Mol Ther2004,9,4:1
9Phase Ⅱ trial of CHOP chemotherapy followed by tositumomab/iodine ^131I tositumomab for previously untreated follicular non-Hodgkin's lymphoma: five-year follow-up of Southwest Oncology Group Protocol S9911显示文摘Press OW 2007J Clinical Oncology2007,25,7:1
10Phase Ⅱ trial of CHOP chemotherapy followed by tositumomab/iodine I-131 tositumomab for previously untreated follicular non-Hodgkin's lymphoma:five-year follow-up of Southwest Oncology Group Protoco S9911显示文摘Press OW Unger JM Braziel RM 2006J Clin Oncol2006,24,25:1
11Synergistic effects of the fenretinide (4-HPR) and anti-CD20 monoclonal antibodies on apoptosis induction of malignant human B cells 显示文摘Shan D Gopal AK Press OW 2001Clin Cancer Res2001,7,8:1
12Signaling events invoJved in anti-CD20-induced apoptosis of malignant human B cells 显示文摘Shah D Ledbetter JA Press OW 2000Cancer Immunol Immunother2000,48,12:1
13Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies 显示文摘Shan D Ledbetter JA Press OW 1998Blood1998,91,5:1
14Signaling events involved in anti-CD20 induced apoptosis of malignant human B cells显示文摘Shah D Ledbetter JA Press OW 2000Cancer Im-munol Immunother2000,48,12:1
15Management of malignant pericardial diffusion and tamponade显示文摘Press OW Livingstion R 1987SAMS1987,257,:1
16Postoperative chylous ascites diagnosis and treatmen 显示文摘Browse NL Press OW 1992Br J Surg1992,79,12:1
17Phase Ⅱ trial of CHOP chemotherapy followed by tositumomab/iedine I-131 tositumomab for previously untreated follicular non-Hodgkin's lymphoma: five- year follow-up of Southwest Oncology Group Protocol S9911 显示文摘Press OW Unger JM Braziel RM 2006J Clin Oncol2006,24,:1
18Phase Ⅱ trial of CHOP chemotherapy followed by tositumomab/iodine I-131 tositumomab for previously untreated follicular non-Hodgkin's lymphoma: five- year follow-up of Southwest Oncology Group Protocol S9911 显示文摘Press OW Unger JM Braziel RM 2006J Clin Oncol2006,24,25:1
19Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies显示文摘Press OW Farr AG Borroz KI 1989Cancer Res1989,49,:1
20Signaling events involved in anti-CD20-induced apoptosis of malignant human B cells显示文摘Shan D Ledbetter JA Press OW 2000Cancer Immunol Immunother2000,48,12:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费